成大生物:聘任李业基为公司董事会秘书

Group 1 - The core point of the news is the announcement by Chengda Biological (SH 688739) regarding a change in its board secretary position, with Mr. Li Yeji appointed as the new board secretary while Mr. Cui Jianwei continues in other roles [1] - Chengda Biological's revenue composition for the year 2024 is entirely from biopharmaceuticals, accounting for 100.0% [1] - As of the announcement, Chengda Biological has a market capitalization of 11.9 billion yuan [1]